Pathogen Detection and Community Acquired Pneumonia

Sponsored by Providence Health & Services

Phase Quota
Phase N/A

Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using current diagnostic tests to the number detected using the BioFire Diagnostics investigational polymerase chain reaction (PCR) platform.

Study Start Date: November 2016

Estimated Completion Date: December 2018

Specialties: Internal Medicine: Pulmonology Infectious Disease: Pulm/Thoracic Infections Pulmonology: Pulm/Thoracic Infections


  • Other: BioFire LRT Multiplex FilmArray PCR panel

Inclusion criteria

  • Emergency Department physician diagnosis of CAP requiring hospitalization

Exclusion criteria

  • Inability to obtain sputum or sputum equivalent

Study Locations And Contact Information

  • Portland Providence Medical Center, Portland Oregon

Feature this Clinical Trial

Get your trial in front of 1000s of physicians and patients.
Visit to find out how you can feature this clinical trial.